EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-11.93%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$3.06B
AUM Growth
+$226M
(+8%)
Cap. Flow
+$578M
Cap. Flow
% of AUM
18.9%
Top 10 Holdings %
Top 10 Hldgs %
83.2%
Holding
374
New
73
Increased
133
Reduced
109
Closed
49
Top Buys
| 1 |
Alibaba
BABA
|
$315M |
| 2 |
Baidu
BIDU
|
$74M |
| 3 |
JD.com
JD
|
$72M |
| 4 |
NetEase
NTES
|
$47.9M |
| 5 |
Pinduoduo
PDD
|
$39.6M |
Top Sells
| 1 |
NIO
NIO
|
$10.7M |
| 2 |
KC
Kingsoft Cloud Holdings
KC
|
$9.2M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$7.55M |
| 4 |
Invesco QQQ Trust
QQQ
|
$7.48M |
| 5 |
United States Brent Oil Fund
BNO
|
$6.73M |
Sector Composition
| 1 | Consumer Discretionary | 63.45% |
| 2 | Communication Services | 21.89% |
| 3 | Technology | 6.77% |
| 4 | Healthcare | 2.13% |
| 5 | Financials | 1.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Copart
CPRT
$47B
| $328K | 0.01% |
10,464
-208
| -2% | -$6.52K |
|
177
NextEra Energy, Inc.
NEE
$146B
| $324K | 0.01% |
3,828
-501
| -12% | -$42.4K |
|
178
CareDx
CDNA
$736M
| $322K | 0.01% |
+8,715
| New | +$322K |
|
179
Arcturus Therapeutics
ARCT
$485M
| $321K | 0.01% |
+11,910
| New | +$321K |
|
180
Linde
LIN
$220B
| $319K | 0.01% |
1,000
-135
| -12% | -$43.1K |
|
181
Intellia Therapeutics
NTLA
$1.29B
| $318K | 0.01% |
+4,377
| New | +$318K |
|
182
Zscaler
ZS
$42.7B
| $318K | 0.01% |
1,316
| – | – |
|
183
BridgeBio Pharma
BBIO
$10.2B
| $317K | 0.01% |
+31,264
| New | +$317K |
|
184
Vir Biotechnology
VIR
$732M
| $316K | 0.01% |
+12,283
| New | +$316K |
|
185
Apellis Pharmaceuticals
APLS
$3.55B
| $315K | 0.01% |
+6,196
| New | +$315K |
|
186
Veracyte
VCYT
$2.55B
| $311K | 0.01% |
+11,276
| New | +$311K |
|
187
Fate Therapeutics
FATE
$116M
| $310K | 0.01% |
7,996
+4,468
| +127% | +$173K |
|
188
Ionis Pharmaceuticals
IONS
$9.76B
| $309K | 0.01% |
+8,334
| New | +$309K |
|
189
Halozyme
HALO
$8.76B
| $308K | 0.01% |
7,726
+2,699
| +54% | +$108K |
|
190
United Parcel Service
UPS
$72.1B
| $305K | 0.01% |
1,423
-184
| -11% | -$39.4K |
|
191
Twist Bioscience
TWST
$1.55B
| $303K | 0.01% |
+6,126
| New | +$303K |
|
192
Emergent Biosolutions
EBS
$404M
| $302K | 0.01% |
+7,354
| New | +$302K |
|
|
BPMC
193
DELISTED
Blueprint Medicines
BPMC
| $300K | 0.01% |
+4,698
| New | +$300K |
|
194
Keysight
KEYS
$28.9B
| $300K | 0.01% |
1,901
+111
| +6% | +$17.5K |
|
195
Exact Sciences
EXAS
$10.2B
| $299K | 0.01% |
+4,275
| New | +$299K |
|
196
Inovio Pharmaceuticals
INO
$148M
| $299K | 0.01% |
6,942
+4,561
| +192% | +$196K |
|
197
Karyopharm Therapeutics
KPTI
$57.2M
| $299K | 0.01% |
2,705
+1,879
| +227% | +$208K |
|
198
Dynavax Technologies
DVAX
$1.18B
| $298K | 0.01% |
27,513
+14,567
| +113% | +$158K |
|
199
Ultragenyx Pharmaceutical
RARE
$3.07B
| $298K | 0.01% |
+4,101
| New | +$298K |
|
200
Arrowhead Research
ARWR
$4.02B
| $295K | 0.01% |
+6,421
| New | +$295K |
|